Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lam Jennifer — OnKure Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Lam Jennifer

Lam Jennifer

VP of Finance & Administration at OnKure Therapeutics, Inc. · on record since Apr 5, 2022

Insider trading activity of Lam Jennifer

Transactions on record: 1; since Dec 13, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 13, 2022

Figures computed from official regulatory filings — methodology.

Companies where Lam Jennifer has traded

OnKure Therapeutics, Inc.1 tx · Dec 13, 2022

Track record of Lam Jennifer

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lam Jennifer

Co-insiders of Lam Jennifer

Access Industries Holdings LLCOnKure Therapeutics, Inc.
ACCESS INDUSTRIES MANAGEMENT, LLCOnKure Therapeutics, Inc.
ACORN BIOVENTURES 2, L.P.OnKure Therapeutics, Inc.
ACORN BIOVENTURES, L.P.OnKure Therapeutics, Inc.
Acorn Capital Advisors GP 2, LLCOnKure Therapeutics, Inc.
ACORN CAPITAL ADVISORS GP, LLCOnKure Therapeutics, Inc.
Agresta SamuelOnKure Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

AI Biotechnology LLCOnKure Therapeutics, Inc.

BASKETT FORESTOnKure Therapeutics, Inc.

Blavatnik LenOnKure Therapeutics, Inc.

Blunt Roshawn A.OnKure Therapeutics, Inc.

Cardon LonOnKure Therapeutics, Inc.

Carruthers R MichaelOnKure Therapeutics, Inc.

Chen BihuaOnKure Therapeutics, Inc.

Cormorant Asset Management, LPOnKure Therapeutics, Inc.

Cormorant Global Healthcare Master Fund, LPOnKure Therapeutics, Inc.

Cormorant Private Healthcare Fund III LPOnKure Therapeutics, Inc.

Cormorant Private Healthcare Fund IV LPOnKure Therapeutics, Inc.

Cormorant Private Healthcare Fund V LPOnKure Therapeutics, Inc.

Cruse MichaelOnKure Therapeutics, Inc.

Dorenbaum AlejandroOnKure Therapeutics, Inc.

Dube Eric MOnKure Therapeutics, Inc.

FLESHER GREGORY J.OnKure Therapeutics, Inc.

Florence Anthony A. Jr.OnKure Therapeutics, Inc.

GREY MICHAEL GOnKure Therapeutics, Inc.

Hall AshleyOnKure Therapeutics, Inc.

Harrison Kenneth Ph.D.OnKure Therapeutics, Inc.

Hartley DylanOnKure Therapeutics, Inc.

Hoelscher Paul W.OnKure Therapeutics, Inc.

Hove Anders DOnKure Therapeutics, Inc.

Jansen Valerie MalyvanhOnKure Therapeutics, Inc.

Jindal Vineet R.OnKure Therapeutics, Inc.

Johnson Wendy S.OnKure Therapeutics, Inc.

Kordel JohanOnKure Therapeutics, Inc.

Leonard Braden MichaelOnKure Therapeutics, Inc.

Leverone Jason A.OnKure Therapeutics, Inc.

Makhzoumi MohamadOnKure Therapeutics, Inc.

MAKOWER JOSHUAOnKure Therapeutics, Inc.

Manke IsaacOnKure Therapeutics, Inc.

Mathers Edward TOnKure Therapeutics, Inc.

Muralidhar BaliOnKure Therapeutics, Inc.

NEA 15 GP, LLCOnKure Therapeutics, Inc.

NEA Partners 15, L.P.OnKure Therapeutics, Inc.

New Enterprise Associates 15, L.P.OnKure Therapeutics, Inc.

Novo A/SOnKure Therapeutics, Inc.

O'Donnell NiallOnKure Therapeutics, Inc.

Phillips Andrew JohnOnKure Therapeutics, Inc.

Ratcliffe LiamOnKure Therapeutics, Inc.

RiverVest Venture Fund III, L.P.OnKure Therapeutics, Inc.

RiverVest Venture Fund III (Ohio), L.P.OnKure Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
OnKure Therapeutics, Inc.	Dec 13, 2022	AwardD	90,000	0.00 USD	$0	SEC